$9.73-0.22 (-2.16%)
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
Perrigo Company plc in the Healthcare sector is trading at $9.73 with a market capitalization of $1.5B. Wall Street consensus targets $16.50 (4 analysts), implying a +69.5% move over the next 12 months. The stock is currently near its 52-week low of $9.23, remaining 28.5% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 22 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $969.20M↓ | $1.11B↑ | $1.04B↓ | $1.06B↑ | $1.04B |
| Gross Profit | $325.50M↓ | $362.20M↓ | $377.10M↑ | $362.90M↓ | $392.30M |
| Operating Income | $33.60M↓ | $84.40M↓ | $93.40M↑ | $55.60M↓ | $79.40M |
| Net Income | -$398.60M↑ | -$1.42B↓ | $7.50M↑ | -$8.40M↓ | -$6.40M |
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper res...
Stryker (SYK) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
The US Food and Drug Administration said Thursday it is requesting updates to prescribing informatio
Perrigo Company plc (NYSE:PRGO) was among Jim Cramer’s stock calls on Mad Money, as he highlighted worthy space players and reviewed several of this year’s IPOs. A caller asked whether the stock’s depressed valuation, ongoing management-led restructuring, and debt-reduction efforts indicate a turnaround opportunity or a value trap. Cramer said: No, I mean, this is […]
Perrigo (NYSE:PRGO) appointed Albert A. Manzone as Interim CEO and President after Patrick Lockwood-Taylor resigned. The Board stated that Lockwood-Taylor’s resignation followed conduct inconsistent with Perrigo’s Code of Conduct. The company has started a comprehensive search for a permanent CEO. Perrigo, trading at $11.61, is undergoing a significant leadership shift at a time when the stock has faced pressure over multiple time frames. The share price is down 16.4% year to date and down...
Perrigo Chief Executive Patrick Lockwood-Taylor has resigned after the board found his personal conduct had violated company code.